Overview

Coenzyme Q10 as Treatment for Long Term COVID-19

Status:
Recruiting

Trial end date:
2021-12-31

Target enrollment:

Participant gender:

Summary

This study is a randomized, placebo-controlled, double-blinded, cross-over designed clinical trial investigating the effect of high-dose Coenzyme Q10 treatment in subjects with persisting symptoms more than 12 weeks af SARS-CoV-2 infection, Long Term COVID-19 (LTC).

Phase:

Phase 2

Details

Lead Sponsor:

Aarhus University Hospital

Collaborators:

Pharma Nord
University of Aarhus

Treatments:

Coenzyme Q10
Ubiquinone